Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Antibodies to periodontal pathogens and coronary artery calcification in type 1 diabetic and nondiabetic subjects.

Colhoun HM, Slaney JM, Rubens MB, Fuller JH, Sheiham A, Curtis MA.

J Periodontal Res. 2008 Feb;43(1):103-10. doi: 10.1111/j.1600-0765.2007.01001.x.

PMID:
18230111
2.

Mechanisms of evasion of complement by Porphyromonas gingivalis.

Slaney JM, Curtis MA.

Front Biosci. 2008 Jan 1;13:188-96. Review.

PMID:
17981537
3.

Mechanisms of resistance of Porphyromonas gingivalis to killing by serum complement.

Slaney JM, Gallagher A, Aduse-Opoku J, Pell K, Curtis MA.

Infect Immun. 2006 Sep;74(9):5352-61.

4.

Identification and characterization of the capsular polysaccharide (K-antigen) locus of Porphyromonas gingivalis.

Aduse-Opoku J, Slaney JM, Hashim A, Gallagher A, Gallagher RP, Rangarajan M, Boutaga K, Laine ML, Van Winkelhoff AJ, Curtis MA.

Infect Immun. 2006 Jan;74(1):449-60.

5.

Structural analysis of a novel anionic polysaccharide from Porphyromonas gingivalis strain W50 related to Arg-gingipain glycans.

Paramonov N, Rangarajan M, Hashim A, Gallagher A, Aduse-Opoku J, Slaney JM, Hounsell E, Curtis MA.

Mol Microbiol. 2005 Nov;58(3):847-63.

6.

Critical pathways in microbial virulence.

Curtis MA, Slaney JM, Aduse-Opoku J.

J Clin Periodontol. 2005;32 Suppl 6:28-38. Review.

PMID:
16128827
7.

Glycosylation of the Arg-gingipains of Porphyromonas gingivalis and comparison with glycoconjugate structure and synthesis in other bacteria.

Gallagher A, Aduse-Opoku J, Rangarajan M, Slaney JM, Curtis MA.

Curr Protein Pept Sci. 2003 Dec;4(6):427-41. Review.

PMID:
14683428
8.

Oro-dental bacteria in various atherosclerotic arteries.

Taylor-Robinson D, Aduse-Opoku J, Sayed P, Slaney JM, Thomas BJ, Curtis MA.

Eur J Clin Microbiol Infect Dis. 2002 Oct;21(10):755-7. Epub 2002 Oct 3.

PMID:
12415477
9.

Nuclear targeting of Porphyromonas gingivalis W50 protease in epithelial cells.

Scragg MA, Alsam A, Rangarajan M, Slaney JM, Shepherd P, Williams DM, Curtis MA.

Infect Immun. 2002 Oct;70(10):5740-50.

10.

Recognition of the carbohydrate modifications to the RgpA protease of Porphyromonas gingivalis by periodontal patient serum IgG.

Slaney JM, Rangarajan M, Aduse-Opoku J, Fawell S, Darby I, Kinane D, Curtis MA.

J Periodontal Res. 2002 Jun;37(3):215-22.

PMID:
12113557
11.

Generation of lys-gingipain protease activity in Porphyromonas gingivalis W50 is independent of Arg-gingipain protease activities.

Aduse-Opoku J, Davies NN, Gallagher A, Hashim A, Evans HE, Rangarajan M, Slaney JM, Curtis MA.

Microbiology. 2000 Aug;146 ( Pt 8):1933-40.

PMID:
10931897
12.

Variable carbohydrate modifications to the catalytic chains of the RgpA and RgpB proteases of Porphyromonas gingivalis W50.

Curtis MA, Thickett A, Slaney JM, Rangarajan M, Aduse-Opoku J, Shepherd P, Paramonov N, Hounsell EF.

Infect Immun. 1999 Aug;67(8):3816-23.

13.

The relationship between colonization and haemagglutination inhibiting and B cell epitopes of Porphyromonas gingivalis.

Kelly CG, Booth V, Kendal H, Slaney JM, Curtis MA, Lehner T.

Clin Exp Immunol. 1997 Nov;110(2):285-91.

14.
15.

The prpR1 and prR2 arginine-specific protease genes of Porphyromonas gingivalis W50 produce five biochemically distinct enzymes.

Rangarajan M, Aduse-Opoku J, Slaney JM, Young KA, Curtis MA.

Mol Microbiol. 1997 Mar;23(5):955-65.

16.

Characterization of an adherence and antigenic determinant of the ArgI protease of Porphyromonas gingivalis which is present on multiple gene products.

Curtis MA, Aduse-Opoku J, Slaney JM, Rangarajan M, Booth V, Cridland J, Shepherd P.

Infect Immun. 1996 Jul;64(7):2532-9.

17.

Characterization, genetic analysis, and expression of a protease antigen (PrpRI) of Porphyromonas gingivalis W50.

Aduse-Opoku J, Muir J, Slaney JM, Rangarajan M, Curtis MA.

Infect Immun. 1995 Dec;63(12):4744-54.

18.

Production and characterisation of monoclonal antibodies to the principle sonicate antigens of Porphyromonas gingivalis w50.

Millar DJ, Scott EE, Slaney JM, U S, Benjamin P, Curtis MA.

FEMS Immunol Med Microbiol. 1993 Oct;7(3):211-22.

PMID:
8275052
19.

Platelet activation by Protease I of Porphyromonas gingivalis W83.

Curtis MA, Macey M, Slaney JM, Howells GL.

FEMS Microbiol Lett. 1993 Jun 15;110(2):167-73.

PMID:
8394260
20.
21.

Interaction of a trypsin-like enzyme of Porphyromonas gingivalis W83 with antithrombin III.

Curtis MA, Slaney JM, Carman RJ, Pemberton PA.

FEMS Microbiol Lett. 1993 Apr 1;108(2):169-74.

PMID:
8486244
22.
23.
24.

Correlation between immune complexes and prognostic factors in Hodgkin's disease.

Amlot PL, Pussell B, Slaney JM, Williams BD.

Clin Exp Immunol. 1978 Feb;31(2):166-73. No abstract available.

25.

Circulating immune complexes and symptoms in Hodgkin's disease.

Amlot PL, Slaney JM, Williams BD.

Lancet. 1976 Feb 28;1(7957):449-51.

PMID:
55719
26.

Classical pathway activation of complement system by IgA anti-C3 antibody.

Williams BD, Slaney JM, Price JF, Challacombe SJ.

Nature. 1976 Jan 1-8;259(5538):52-3. No abstract available.

PMID:
1250339
27.

Immunoconglutinins and C3 in human saliva.

Williams BD, Challacombe SJ, Slaney JM, Lachmann PJ, Lehner T.

Clin Exp Immunol. 1975 Mar;19(3):423-33.

Supplemental Content

Loading ...
Support Center